Literature DB >> 11930947

Is a 0900-h serum cortisol useful prior to a short synacthen test in outpatient assessment?

C W Le Roux1, K Meeran, J Alaghband-Zadeh.   

Abstract

BACKGROUND: The short synacthen test (SST) is the gold standard investigation for the evaluation of adrenal insufficiency and is also frequently used for the evaluation of the hypothalamic-pituitary-adrenal (HPA) axis. The 0900-h serum cortisol concentration has also been evaluated as an indication of cortisol reserve, and a result > 450 nmol/L is highly suggestive of a normal serum cortisol response to the insulin tolerance test, while no patient with a 0900-h serum cortisol < 100 nmol/L had a sufficient response. The aim of this study was to determine if the number of inappropriate SSTs could be reduced if a 0900-h serum total cortisol was done prior to the dynamic function test.
METHOD: Two hundred and ten SSTs were performed at 0900 h and the response at 30 min evaluated.
RESULTS: Of the 210 SST, 151 (71%) demonstrated a maximum response at 30 min of serum cortisol > 550 nmol/L. All the patients with a 0900-h serum cortisol > 500 nmol/L had an adequate response ( > 550 nmol/L), while no patient with a 0900-h serum cortisol of < 100 nmol/L had an adequate SST response. Twenty one per cent of patients were shown to have had an unnecessary invasive procedure.
CONCLUSION: We conclude that the SST is of little added value in patients with a 0900-h serum cortisol of less than 100 nmol/L or more than 500 nmol/L and it should be included in the appropriate protocols for endocrine investigation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11930947     DOI: 10.1258/0004563021901919

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  26 in total

1.  Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug.

Authors:  Laurie S Conklin; Jesse M Damsker; Eric P Hoffman; William J Jusko; Panteleimon D Mavroudis; Benjamin D Schwartz; Laurel J Mengle-Gaw; Edward C Smith; Jean K Mah; Michela Guglieri; Yoram Nevo; Nancy Kuntz; Craig M McDonald; Mar Tulinius; Monique M Ryan; Richard Webster; Diana Castro; Richard S Finkel; Andrea L Smith; Lauren P Morgenroth; Adrienne Arrieta; Maya Shimony; Mark Jaros; Phil Shale; John M McCall; Yetrib Hathout; Kanneboyina Nagaraju; John van den Anker; Leanne M Ward; Alexandra Ahmet; Michaelyn R Cornish; Paula R Clemens
Journal:  Pharmacol Res       Date:  2018-09-13       Impact factor: 7.658

2.  Value of basal serum cortisol to detect corticosteroid-induced adrenal insufficiency in elite cyclists.

Authors:  M Guinot; M Duclos; N Idres; J C Souberbielle; A Megret; Yves Le Bouc
Journal:  Eur J Appl Physiol       Date:  2006-11-07       Impact factor: 3.078

Review 3.  Adrenal suppression from exogenous glucocorticoids: Recognizing risk factors and preventing morbidity.

Authors:  Alexandra Ahmet; Anne Rowan-Legg; Larry Pancer
Journal:  Paediatr Child Health       Date:  2021-06-11       Impact factor: 2.600

4.  Hypothalamic-pituitary-adrenal axis function in ankylosing spondylitis.

Authors:  R Imrich; J Rovensky; M Zlnay; Z Radikova; L Macho; M Vigas; J Koska
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

5.  Screening for Addison's disease in patients with type 1 diabetes mellitus and recurrent hypoglycaemia.

Authors:  Taruna Likhari; Saeed Magzoub; Melanie J Griffiths; Harit N Buch; R Gama
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

Review 6.  Organ-specific Adverse Events of Immune Checkpoint Inhibitor Therapy, with Special Reference to Endocrinopathies.

Authors:  Annu Susan George; Cornelius J Fernandez; Dilip Eapen; Joseph M Pappachan
Journal:  touchREV Endocrinol       Date:  2021-04-28

7.  Pituitary apoplexy.

Authors:  Salam Ranabir; Manash P Baruah
Journal:  Indian J Endocrinol Metab       Date:  2011-09

Review 8. 

Authors:  Alexandra Ahmet; Anne Rowan-Legg; Larry Pancer
Journal:  Paediatr Child Health       Date:  2021-06-11       Impact factor: 2.600

Review 9.  Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Stefan R Bornstein; Bruno Allolio; Wiebke Arlt; Andreas Barthel; Andrew Don-Wauchope; Gary D Hammer; Eystein S Husebye; Deborah P Merke; M Hassan Murad; Constantine A Stratakis; David J Torpy
Journal:  J Clin Endocrinol Metab       Date:  2016-01-13       Impact factor: 5.958

10.  Screening practices for paediatric asymptomatic adrenal suppression in Canada: Are we addressing this important risk?

Authors:  Ellen B Goldbloom; Alexandra Ahmet
Journal:  Paediatr Child Health       Date:  2019-03-30       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.